Document is current
Any future updates will be listed below
-
Authors
Sadiq, Mohammad Ali
Hassan, Muhammad
Afridi, Rubbia
Halim, Muhammad Sohail
Do, Diana V.
Sepah, Yasir J.
Nguyen, Quan Dong https://orcid.org/0000-0002-6024-8441
,
- License Information
-
More Information
Article History
Received: 25 March 2020
Accepted: 4 September 2020
First Online: 6 October 2020
Ethics approval and consent to participate and publish
: The study was conducted in compliance with the United States Code of Federal Regulations Title 21, the Declaration of Helsinki, and the Harmonized Tripartite Guidelines for Good Clinical Practice (1996). The study was approved by local institutional review boards for selected sites and by a central review board for others. Signed informed consent were obtained from all the participants in the study.
: Not applicable.
: YJS has received research support from Astellas, Genentech, and Optovue, and serves on the Scientific Advisory Board for Genentech/Roche, Optos, and Regeneron. QDN serves on the Scientific Advisory Board for AbbVie, Bayer, Genentech, Regeneron, and Santen, among others. QDN also chaired the Steering Committee for the STOP-Uveitis Study and was on the Steering Committee for other studies sponsored by Genentech and Regeneron. DVD serves on the Scientific Advisory Board for Allergan, Genentech, Kodiak, Regeneron, and Santen and she has received research support from Genentech and Regeneron. No other authors have received any financial funding or support.
